Innerer Wert von S&P & Nasdaq Kontaktieren

Aclarion, Inc. ACONW NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
46/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Aclarion, Inc. (ACONW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysten schätzen Gewinn pro Aktie (EPS) von $-7,371.68 und Umsatz von $0.00B für das nächste Geschäftsjahr.

Gewinn pro Aktie (EPS) Erfolgsbilanz: 2024: tatsächlich $-7,480.21 vs Schätzung $-7,371.68 (verfehlt -1.5%). 2025: tatsächlich $-13.61 vs Schätzung $-15.13 (übertroffen +10%). Analysten-Genauigkeit: 94%.

GpA-Schätzungen — ACONW

94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$7,480.21 vs Est –$7,371.68 ▼ 1.5% off
2025 Actual –$13.61 vs Est –$15.13 ▲ 11.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.

Umsatzschätzungen — ACONW

89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.000B vs Est $0.000B ▼ 20.3% off
2025 Actual $0.000B vs Est $0.000B ▼ 1.7% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden